Influence of nutritional status and body mass index of patients on the prognosis and course of chronic obstructive pulmonary disease

Abstract

The problem of the relationship of nutritional status with the risk of development, course features and prognosis of chronic obstructive pulmonary disease is of considerable scientific and practical interest, but remains poorly understood. However, in clinical practice, it is customary to calculate only the body mass index, but this indicator cannot provide a complete characterization of the nutritional status. We have reviewed the data of publications indicating the conditionality of the course of chronic obstructive pulmonary disease by the value of the body mass index, the amount of muscle mass of the body and such parameters of adipose tissue as its distribution in the body, hormonal activity and production of systemic chronic inflammation markers. To assess the dynamics of body mass index and spirometric parameters in patients with chronic obstructive pulmonary disease, 76 publications that were selected by the keywords “COPD”, “BMI” in the Scopus, PubMed, eLibrary databases for 1995–2022, were analyzed. Correlation analysis was carried out using Spearman's test. As a result, there was a trend towards an increase in body mass index in patients with chronic obstructive pulmonary disease in different countries and an improvement in spirographic parameters in a cohort of patients with chronic obstructive pulmonary disease over time. The data of the reviewed studies indicate the presence of a relationship between chronic obstructive pulmonary disease and nutritional status. At the same time, the mechanisms of the relationship between the pathogenesis of chronic obstructive pulmonary disease and adipose tissue dysfunction, as well as the role of adipose tissue and body composition in the course of the disease and its prognosis, have not been sufficiently studied.

Keywords

BMI / COPD / nutritional status / body composition / review

References

[1] Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2022 Report). 2022. https://goldcopd.org/ (access date: 14.11.2022).

[2] Akparova AY, Abdrakhmanova BM, Imanbay AK, Kazhiyahmetova BB, Bersimbay RI. Features of the pathogenesis of chronic obstructive pulmonary disease and its comorbid conditions. Vestnik KazNMU. 2019;(1):283–287. (In Russ.)

[3] Акпарова А.Ю., Абдрахманова Б.М., Иманбай А.К., Кажияхметова Б.Б., Берсимбай Р.И. Особенности патогенеза хронической обструктивной болезни лёгких и её коморбидных состояний. Вестник КазНМУ. 2019;(1):283–287. EDN: RXPYAS.

[4] Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: Systematic review and critical appraisal. BMJ. 2019;367:15358. DOI: 10.1136/bmj.l5358.

[5] Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012. DOI: 10.1056/NEJMoa021322.

[6] Wada H, Ikeda A, Maruyama K, Yamagishi K, Barnes PJ, Tanigawa T, Tamakoshi A, Iso H. Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: The JACC study. Sci Rep. 2021;11(1):1531. DOI: 10.1038/s41598-020-79860-4.

[7] Shin SH, Kwon SO, Kim V, Silverman EK, Kim TH, Kim DK, Hwang YI, Yoo KH, Kim WJ, Park HY. Association of body mass index and COPD exacerbation among patients with chronic bronchitis. Respir Res. 2022;23(1):52. DOI: 10.1186/s12931-022-01957-3.

[8] Guo Y, Zhang T, Wang Z, Yu F, Xu Q, Guo W, Wu C, He J. Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis. Medicine (Baltimore). 2016;95(28):e4225. DOI: 10.1097/MD.0000000000004225.

[9] McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, Bamman M, Celli B, Agusti A, Tal-Singer R, Hersh CP, Dransfield M, Silverman EK. It's more than low BMI: Prevalence of cachexia and associated mortality in COPD. Respir Res. 2019;20(1):100. DOI: 10.1186/s12931-019-1073-3.

[10] Colak Y, Afzal S, Lange P, Nordestgaard BG. High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study. Int J Epidemiol. 2016;45:1551–1561. DOI: 10.1093/ije/dyw051.

[11] Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Koch A, Schulz H, Watz H, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016;16(1):70. DOI: 10.1186/s12890-016-0238-9.

[12] Huber MB, Kurz C, Kirsch F, Schwarzkopf L, Schramm A, Leidl R. The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data. Respir Res. 2020;21(1):291. DOI: 10.1186/s12931-020-01556-0.

[13] Huber MB, Schneider N, Kirsch F, Schwarzkopf L, Schramm A, Leidl R. Long-term weight gain in obese COPD patients participating in a disease management program: A risk factor for reduced health-related quality of life. Respir Res. 2021;22:226. DOI: 10.1186/s12931-021-01787-9.

[14] Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. DOI: 10.1183/09031936.00128008.

[15] Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr. 2005;82(5):996–1003. DOI: 10.1093/ajcn/82.5.996.

[16] Kirsch F, Schramm A, Kurz C, Schwarzkopf L, Lutter JI, Huber M, Leidl R. Effect of BMI on health care expenditures stratified by COPD GOLD severity grades: Results from the LQ-DMP study. Respir Med. 2020;175:106–194. DOI: 10.1016/j.rmed.2020.106194.

[17] Koniski M, Salhi H, Lahlou A, Rashid N, El Hasnaoui A. Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: Data from the BREATH study. Int J Chron Obstruct Pulmon Dis. 2015;10(1):1685–1694. DOI: 10.2147/COPD.S87259.

[18] Franssen FM, O'Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63(12):1110–1117. DOI: 10.1136/thx.2007.086827.

[19] Dedov II, Mel’nichenko GA, Butrova SA. Adipose tissue as an endocrine organ. Obesity and metabolism. 2006;3(1):6–13. (In Russ.)

[20] Дедов И.И., Мельниченко Г.А., Бутрова С.А. Жировая ткань как эндокринный орган. Ожирение и метаболизм. 2006;3(1):6–13. EDN: KZWGBZ.

[21] Unamuno X, Gómez-Ambrosi J, Rodríguez A, Becerril S, Frühbeck G, Catalán V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018;48(9):e12997. DOI: 10.1111/eci.12997.

[22] Gould JM, Weiser JN. Expression of C-reactive protein in the human respiratory tract. Infect Immun. 2001;69(3):1747–1754. DOI: 10.1128/IAI.69.3.1747-1754.2001.

[23] Ovsyannikov ES, Avdeev SN, Budnevsky AV. Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity. Therapeutic archive. 2020;92(3):13–18. (In Russ.) DOI: 10.26442/00403660.2020.03.000265.

[24] Овсянников E.С., Авдеев С.Н., Будневский А.В. Системное воспаление у больных хронической болезнью лёгких и ожирением. Терапевтический архив. 2020;92(3):13–18. DOI: 10.26442/00403660.2020.03.000265.

[25] Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370:797–799. DOI: 10.1016/S0140-6736(07)61383-X.

[26] Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci (Lond). 2016;130(13):1039–1050. DOI: 10.1042/CS20160043.

[27] Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ, Celli B. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PloS ONE. 2012;7(5):e37483. DOI: 10.1371/journal.pone.0037483.

[28] Rodrigues F, Papoila AL, Ligeiro D, Gomes MJ, Trindade H. Acute exercise amplifies inflammation in obese patients with COPD. Rev Port Pneumol. 2016;22(6):315–322. DOI: 10.1016/j.rppnen.2016.05.005.

[29] Garcia-Aymerich J, Gómez FP, Benet M, Farrero E, Basagaña X, Gayete À, Paré C, Freixa X, Ferrer J, Ferrer A, Roca J, Gáldiz JB, Sauleda J, Monsó E, Gea J, Barberà JA, Agustí À, Antó JM; PAC-COPD Study Group. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 2011;66(5):430–437. DOI: 10.1136/thx.2010.154484.

[30] He H, Wang B, Zhou M, Cao L, Qiu W, Mu G, Chen A, Yang S, Chen W. Systemic inflammation mediates the associations between abdominal obesity indices and lung function decline in a Chinese general population. Diabetes Metab Syndr Obes. 2020;13:141–150. DOI: 10.2147/DMSO.S229749.

[31] Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, Guize L, Zureik M. Lung function impairment and metabolic syndrome: The critical role of abdominal obesity. Am J Respir Crit Care Med. 2009;179(6):509–516. DOI: 10.1164/rccm.200807-1195OC.

[32] Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. Int J Gen Med. 2010; 3:335–343. DOI: 10.2147/IJGM.S11926.

[33] Tanchenko OA, Naryshkina SV. Clinical and functional particuliarities of arterial stiffness under concomitant cardiopulmonary pathology. Bulletin Physiology and Pathology of Respiration. 2018;(67):83–92. (In Russ.) DOI: 10.12737/article_5a9f2b6c723c93.71757652.

[34] Танченко О.А., Нарышкина С.В. Клинико-функциональные особенности артериальной ригидности при сочетанной кардиопульмональной патологии. Бюллетень физиологии и патологии дыхания. 2018;(67):83–92. DOI: 10.12737/article_5a9f2b6c723c93.71757652.

[35] Lambert AA, Putcha N, Drummond MB, Boriek AM, Hanania NA, Kim V, Kinney GL, McDonald MN, Brigham EP, Wise RA, McCormack MC, Hansel NN; COPD Gene Investigators. Obesity is associated with increased morbidity in moderate to severe COPD. Chest. 2017;151(1):68–77. DOI: 10.1016/j.chest.2016.08.1432.

[36] DeLapp DA, Glick C, Furmanek S, Ramirez JA, Cavallazzi R. Patients with obesity have better long-term outcomes after hospitalization for COPD exacerbation. COPD. 2020;17(4):373–377. DOI: 10.1080/15412555.2020.1781805.

[37] Zapatero A, Barba R, Ruiz J, Losa JE, Plaza S, Canora J, Marco J. Malnutrition and obesity: Influence in mortality and readmissions in chronic obstructive pulmonary disease patients. J Hum Nutr Diet. 2013;26(1):16–22. DOI: 10.1111/jhn.12088.

[38] Hancu A. Nutritional status as a risk factor in COPD. Maedica (Bucur). 2019;14(2):140–143. DOI: 10.26574/maedica.2019.14.2.140.

[39] Burtseva EV. Study of the nutritive status of chronic obstructive pulmonary disease patients by using the methods of anthropometry and bioimpedancemetry. Sovremennie problem nauki i obrazovaniya. 2012;(2):86. (In Russ.)

[40] Бурцева Е.В. Исследование нутритивного статуса пациентов ХОБЛ с помощью методов антропометрии и биоимпендансометрии. Современные проблемы науки и образования. 2012;(2):86. EDN: OXCKPP.

[41] Bolotova EV, Dudnikova AV, Yavlyanskaya VV. Body composition in patients with chronic obstructive pulmonary disease. Pulmonologiya. 2018;28(4):453–460. (In Russ.) DOI: 10.18093/0869-0189-2018-28-4-453-459.

[42] Болотова Е.В., Дудникова А.В., Являнская В.В. Особенности исследования состава тела у больных хронической обструктивной болезнью лёгких. Пульмонология. 2018;28(4):453–460. DOI: 10.18093/0869-0189-2018-28-4-453-459.

[43] Gea J, Agustí A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol. 2013;114(9):1222–1234. DOI: 10.1152/japplphysiol.00981.2012.

[44] Shamsutdinova NG, Nurullina GI, Bolshakov NA, Khusainova AK, Dyakova EV. Mechanisms of systemic manifestations chronic obstructive pulmonary disease. Prakticheskaya meditsina. 2018;(7-2):102–108. (In Russ.)

[45] Шамсутдинова Н.Г., Нуруллина Г.И., Большаков Н.А., Хусаинова А.К., Дьякова Е.В. Механизмы системных проявлений хронической обструктивной болезни лёгких. Практическая медицина. 2018;(7-2):102–108. EDN: YNJOIX.

[46] Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:669–675. DOI: 10.2147/COPD.S130790.

[47] Mete B, Pehlivan E, Gülbaş G, Günen H. Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity. Int J Chron Obstruct Pulmon Dis. 2018;13:3307–3312. DOI: 10.2147/COPD.S179609.

[48] Martin M, Almeras N, Després JP, Coxson HO, Washko GR, Vivodtzev I, Wouters EF, Rutten E, Williams MC, Murchison JT, MacNee W, Sin DD, Maltais F. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy. Int J Chron Obstruct Pulmon Dis. 2017;12:451–460. DOI: 10.2147/COPD.S124750.

[49] Alferova VI, Mustafina SV. The prevalence of obesity in the adult population of the Russian Federation (literature review). Obesity and metabolism. 2022;19(1):96–105. (In Russ.) DOI: 10.14341/omet12809.

[50] Алфёрова В.И., Мустафина С.В. Распространённость ожирения во взрослой популяции Российской Федерации (обзор литературы). Ожирение и метаболизм. 2022;19(1):96–105. DOI: 10.14341/omet12809.

Funding

Выполнено при финансовой поддержке ФГБОУ ВО «Сибирский ­государственный медицинский университет» Министерства здравоохранения Российской Федерации в рамках конкурса научно-технических проектов молодых учёных

RIGHTS & PERMISSIONS

Eco-Vector